U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06928545) titled 'MagDI U.S. Registry' on April 08. Brief Summary: Assess the incidence and severity of int... Read More
U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06928077) titled 'Inspiration From Eye-tracking Data: Investigating the Impact of Combining Specific Environ... Read More
U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06926933) titled 'Efficacy and Safety of Leuprolide Acetate 45 mg in Subjects With Central Precocious Pubert... Read More
U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06927947) titled 'Navigation Interventions to Improve Cascade Genetic Testing Among Relatives of Patients Wi... Read More
U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06926777) titled 'Comparative Analysis of Median Nerve Parameters for Carpal Tunnel Syndrome (CTS) Diagnosis... Read More
U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06928454) titled 'Brain Health Project for Korean American Dementia Caregivers' on March 31. Brief Summary:... Read More
U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06927453) titled 'Soft Tissue Healing During Alveolar Ridge Preservation' on April 04. Brief Summary: State... Read More
U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06928753) titled 'Real-world Effectiveness, Safety and Immunogenicity of Chikungunya Vaccination in Populati... Read More
U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06928051) titled 'A Study of S-892216 in Participants With COVID-19' on April 09. Brief Summary: The primar... Read More
U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06926920) titled 'A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants... Read More